| 标题 |
A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:BMC Cancer 作者:Qingyuan Zhang; Zhonghua Wang; Wei Yao; Shufang Wang; Gaochong Zhang; et al 出版日期:2024-09-13 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)